PPCB
Propanc Biopharma Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.13
+0.01 ▲ +5.12%
🌙 3월 13일 7:59 PM ET (한국 3/14 08:59)
$0.12
+0.00 -3.69%
| Index | - | P/E | - | EPS (ttm) | -13.54 | Insider Own | 62.48% | Shs Outstand | 0.01B | Perf Week | -24.73% |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.01B | Perf Month | -45.64% |
| Enterprise Value | 0.00B | PEG | - | EPS next Q | - | Inst Own | 1.26% | Short Float | 4.18% | Perf Quarter | -84.31% |
| Income | -0.07B | P/S | - | EPS this Y | - | Inst Trans | 1.54% | Short Ratio | 0.15 | Perf Half Y | -93.58% |
| Sales | 0.00B | P/B | 0.16 | EPS next 5Y | - | ROA | -869.88% | Short Interest | 0.25M | Perf YTD | -76.3% |
| Book/sh | 0.78 | P/C | 3.61 | EPS past 3/5Y | 98.29% 98.33% | ROE | -2099.56% | 52W High | -98.84% ($11.00) | Perf Year | -98.12% |
| Cash/sh | 0.04 | P/FCF | - | Sales past 3/5Y | - | ROIC | -583.24% | 52W Low | 5.91% ($0.12) | Perf 3Y | -100% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 97.95% | Gross Margin | - | Volatility(W/M) | 15.86% 13.43% | Perf 5Y | -100% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.03 | Perf 10Y | -100% |
| Dividend Ex-Date | - | Quick Ratio | 2.13 | EPS Q/Q | 99.09% | Profit Margin | - | RSI (14) | 26.94 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.13 | Sales Q/Q | - | SMA20 | -29.1% ($0.18) | Beta | 3.51 | Target Price | $380 |
| Payout | - | Debt/Eq | 0.16 | Earnings | - | SMA50 | -53.39% ($0.28) | Rel Volume | 1.65 | Prev Close | $0.12 |
| Employees | 2 | LT Debt/Eq | 0.1 | EPS/Sales Surpr. | - | SMA200 | -94.29% ($2.28) | Avg Volume(3M) | 1.70M | Price | $0.13 |
| IPO | 2012/11/12 | Option/Short | No/Yes | Trades | 946 | Volume | 2,800,610 | Change | 5.12% |
뉴스 로딩 중...